Kidney News and Research

RSS

Origin of SARS-CoV-2 virus well-suited to jump from animals to humans

A team of scientists studying the origin of SARS-CoV-2, the virus that has caused the COVID-19 pandemic, found that it was especially well-suited to jump from animals to humans by shapeshifting as it gained the ability to infect human cells.

30 May 2020

Scientist explore potential drugs to prevent cell resistance in different types of cancer

Cancer therapy may shrink the tumor of a patient, and the patient may feel better. But unseen on a CT scan or MR image, some of the cells are undergoing ominous changes.

29 May 2020

How comorbidities affect SARS-CoV-2 viral entry

Almost from the start of the current COVID-19 pandemic, it has become clear that individuals suffering from other medical conditions like diabetes, cardiovascular disease, and lung disease are far more likely to contract the infection and to have a poorer outcome.

28 May 2020

Scientists from gnomAD Consortium release first set of discoveries on human genetic variation

For the last eight years, the Genome Aggregation Database Consortium (and its predecessor, the Exome Aggregation Consortium, or ExAC), has been working with geneticists around the world to compile and study more than 125,000 exomes and 15,000 whole genomes from populations around the world.

28 May 2020

A closer look at TMPRSS2: This could help treat COVID-19

The transmembrane protease serine-type 2 (TMPRSS2) protein plays a key role in COVID-19 infection since it primes the viral spike protein to allow viral entry into the target cell. A new study by researchers at Imperial College London and published on the preprint server bioRxiv in May 2020 describes the protein, which could be an attractive drug target to help manage COVID-19.

28 May 2020

CBD treatment improves arthritis symptoms in dogs, study finds

A team led by researchers at Baylor College of Medicine in collaboration with Medterra CBD conducted the first scientific studies to assess the potential therapeutic effects of cannabidiol for arthritic pain in dogs, and the results could lead the way to studying its effect in humans.

28 May 2020

Johns Hopkins team develops new method to maintain sufficient supplies of kidney dialysis fluid

The ongoing COVID-19 pandemic has severely impacted the manufacturing and supply chains for many products.

28 May 2020

Clinical study shows promising results for treatment of VHL disease-associated renal tumors

In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor (HIF)-2a was well tolerated and resulted in clinical responses for patients with von Hippel-Lindau disease (VHL)–associated renal cell carcinoma.

28 May 2020

New device allows rapid disease analysis in kidneys affected by diabetes

The amount of scarring in damaged kidneys as a result of diabetes or acute injury, is a key factor in determining treatment. But it has not been possible, using traditional techniques, to quickly and accurately assess how widespread this kind of wounding extends within the organ.

28 May 2020

City experts to develop a hybrid sensor for detection of diabetes

Dr Sumsun Naher and Professor Aziz Rahman have received a Marie Curie Fellowship to develop a hybrid sensor for the detection of diabetes from exhaled breath.

27 May 2020

Simple urine-testing method for people with kidney stones offers results in 30 minutes

An improved urine-testing system for people suffering from kidney stones inspired by nature and proposed by researchers from Penn State and Stanford University may enable patients to receive results within 30 minutes instead of the current turnaround time of a week or more.

27 May 2020

ACE2 receptors in the kidney not linked to high BP or RAS blockers

Even as the COVID-19 pandemic continues to smolder and flare up in various parts of the world, researchers are still trying to make sense of the virus, its routes of spread, its target tissues, and the immune responses it induces. One crucial piece of knowledge is that the primary viral receptor is a human enzyme called angiotensin-converting enzyme 2 (ACE2).

27 May 2020

COVID-19 only kills 1% of people in remote Papuan village with limited resources

A researcher from Vrije Universiteit Amsterdam, The Netherlands, and a tropical medicine expert who lives in Wamena, Indonesia have published a unique account of a village in the Papuan highlands of Indonesia that has experienced what was presumed to be an outbreak of coronavirus disease 2019 (COVID-19)

27 May 2020

Study finds large racial/ethnic differences in use of medication for OUD during pregnancy

Black non-Hispanic and Hispanic women with opioid use disorder are significantly less likely to receive or to consistently use any medication to treat their opioid use disorder during pregnancy than their white non-Hispanic counterparts, according to a new study from Massachusetts General Hospital.

27 May 2020

No-deductible preventive drugs can reduce out-of-pocket costs for diabetic patients

For patients with diabetes - especially those with lower incomes - preventive drug lists (PDLs) of essential medications available with no deductible can reduce out-of-pocket costs while increasing use of important treatments, reports a study in a June supplement to Medical Care.

27 May 2020

Study finds very low level of SARS-CoV-2 in two San Francisco Bay areas

A new study published on the preprint server medRxiv in May 2020 reports a very low prevalence of antibodies in two separate populations living in the San Francisco Bay Area.

26 May 2020

UZH researchers develop new X-ray contrast agent for high-resolution vascular imaging

Various diseases in humans and animals - such as tumors, strokes or chronic kidney disease - damage the blood vessels. Capillaries, the smallest blood vessels in the body, are particularly affected.

26 May 2020

Scientists discover how an obscure protein promotes breast cancer progression

South Australian scientists have made a critical breakthrough, discovering how an obscure protein causes breast cancer to develop and grow more quickly.

25 May 2020

Heparin may stop SARS-CoV-2 infecting host cells

Researchers at the University of Sheffield have developed a new assay that can be used to assess the attachment of viruses to host cells and to test potential inhibitors of viral infection.

24 May 2020

Study shows cats can harbor SARS-CoV-2 without any symptoms

A recent paper from Spanish researchers at the Hospital Universitario San Pedro-CIBIR, available on the medRxiv* preprint server, suggests that cats may act as asymptomatic dispersers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), even though viral transmission from animals to humans still seems highly unlikely.

24 May 2020

Kidney News and Research

Origin of SARS-CoV-2 virus well-suited to jump from animals to humans

Scientist explore potential drugs to prevent cell resistance in different types of cancer

How comorbidities affect SARS-CoV-2 viral entry

Scientists from gnomAD Consortium release first set of discoveries on human genetic variation

A closer look at TMPRSS2: This could help treat COVID-19

CBD treatment improves arthritis symptoms in dogs, study finds

Johns Hopkins team develops new method to maintain sufficient supplies of kidney dialysis fluid

Clinical study shows promising results for treatment of VHL disease-associated renal tumors

New device allows rapid disease analysis in kidneys affected by diabetes

City experts to develop a hybrid sensor for detection of diabetes

Simple urine-testing method for people with kidney stones offers results in 30 minutes

ACE2 receptors in the kidney not linked to high BP or RAS blockers

COVID-19 only kills 1% of people in remote Papuan village with limited resources

Study finds large racial/ethnic differences in use of medication for OUD during pregnancy

No-deductible preventive drugs can reduce out-of-pocket costs for diabetic patients

Study finds very low level of SARS-CoV-2 in two San Francisco Bay areas

UZH researchers develop new X-ray contrast agent for high-resolution vascular imaging

Scientists discover how an obscure protein promotes breast cancer progression

Heparin may stop SARS-CoV-2 infecting host cells

Study shows cats can harbor SARS-CoV-2 without any symptoms

Event guide: 8th CKD Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News